GGrantIndex
← Search

PHASE 1 AND PHASE 2 CLINICAL TRIALS FOR NEXT-GENERATION CORONAVIRUS VACCINES

$277,585,346N01FY2023AINIH

Leidos Biomedical Research, Inc., Frederick MD

Investigators

Abstract

THE OBJECTIVE OF THIS TASK ORDER SUPPORTS NIAID'S GOAL TO CONDUCT A SERIES OF STANDARDIZED PHASE 1 AND PHASE 2 TRIALS ON NEXT-GENERATION VACCINES TO GENERATE DATA TO INFORM DECISIONS ON WHICH CANDIDATE TO ADVANCE.

View original record on NIH RePORTER →